A comparison of visual analog scale and shear-wave ultrasound elastography data in fibromyalgia patients and the normal population

Karayol, Kudret Cem; Karayol, Sunay Sibel

doi:10.1589/jpts.33.40

Cited by 11 publications

(9 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Quantification of taut muscle bands in stiffness assessment is one possibility [100], however, there is no consensus regarding standardisation of muscle groups to be assessed. Furthermore, studies do not reliably show that quantitative stiffness correlates to symptom burden in the FM population [101,102]. Recent studies have shown promise in this technique in assessing post-stroke stiffness [103], but further research to validate this technique in the FM population is warranted.…”

Section: Discussionmentioning

confidence: 99%

Whole-Body Photobiomodulation Therapy for Fibromyalgia: A Feasibility Trial

Fitzmaurice

Heneghan

Rayen

et al. 2023

Preprint

View full text Add to dashboard Cite

Background Effective treatment for fibromyalgia (FM) is lacking and further treatment options are needed. Photobiomodulation therapy (PBMT) represents one potential treatment option. Whilst favourable findings have been reported using localised PBMT, no investigations have established the value of whole-body PBMT for the complete set of symptom domains in FM. Methods A single-arm feasibility study was conducted in accordance to CONSORT (CONsolidated Standards of Reporting Trials) guidelines. A non-probability sampling method was used to access individuals with FM. The primary outcome measure was identified as the Revised Fibromyalgia Impact Questionnaire (FIQR). Forty-nine participants were screened and 21 trial participants entered the trial. Nineteen participants completed the intervention (18 whole-body PBMT sessions over approximately six weeks). Descriptive statistics and qualitative analysis was undertaken to represent feasibility outcomes. Acceptability of the trial device and processes were established. Outcome measures towards efficacy data were guided by core and peripheral OMERACT (outcomes measures in rheumatological clinical trials) domains, utilising a combination of participant-reported and performance-based outcome measures. Data for the embedded qualitative component of the trial were captured by participant-reported experience measures and audio-recorded semi-structured interviews. Results Positive changes were observed for FM-specific quality of life, pain, tenderness, stiffness, fatigue, sleep disturbance, anxiety, depression and cognitive impairment. Patient global assessment revealed improvements at 6 weeks, with continued effect at 24 weeks. FM-specific quality of life at 24 weeks remained improved compared with baseline scores. Conclusions Findings provide evidence to support a full-scale trial and shows promise regarding potential efficacy of this novel non-invasive treatment in an FM population. Trial Registration ClinicalTrials.gov trial; NCT05069363, 06/10/2021

show abstract

Section: Discussionmentioning

confidence: 99%

Whole-Body Photobiomodulation Therapy for Fibromyalgia: A Feasibility Trial

Fitzmaurice

Heneghan

Rayen

et al. 2023

Preprint

View full text Add to dashboard Cite

show abstract

“…Current studies have measured elasticity and stiffness, in relation to changes in soft tissue properties, using different ultrasound techniques, without finding any significant differences between healthy people and patients with FM [ 41 , 42 ]. However, it is necessary to emphasise that these studies used different ultrasound techniques than those used in our study.…”

Section: Discussionmentioning

confidence: 99%

Do Psychological Factors Influence the Elastic Properties of Soft Tissue in Subjects with Fibromyalgia? A Cross-Sectional Observational Study

et al. 2022

View full text Add to dashboard Cite

Nowadays, there is evidence related to the impact that psychological factors have on symptoms, specifically vegetative ones, and on the autonomic nervous system in patients with fibromyalgia (FM). However, there are no studies to correlate the level of association between psychological factors and the elastic properties of tissue in the FM population. Elastic properties of soft tissue reflect age- and disease-related changes in the mechanical functions of soft tissue, and mechanical failure has a profound impact on morbidity and mortality. The study has a cross-sectional observational design with 42 participants recruited from a private clinic and rehabilitation service. The Pain Catastrophizing Scale, Tampa Kinesiophobia Scale and Self-Efficacy Scale were used to assess psychological factors. The elastic properties of the tissue in the characteristic painful points, which patients suffering from FM described, were assessed by strain elastography. A low and significant level of association was found between pain catastrophising scale (PCS) and the non-dominant lateral epicondyle (r = −0.318; p = 0.045). Kinesiophobia was found to be related to the dominant lateral epicondyle (r = 0.403; p = 0.010), the non-dominant knee (r = −0.34; p = 0.027) and the dominant forearm (r = 0.360; p = 0.010). Self-Efficacy showed a low level of association with the non-dominant supraspinatus (r = −0.338; p = 0.033) and the non-dominant medial epicondyle (r = −0.326; p = 0.040). Psychological factors and the elastic properties of tissue seem to be associated in patients suffering from FM. The most profound association between psychological factors and non-dominant parts of the body could be related to neglect and non-use of those parts of the body.

show abstract

“…These authors reported that for all tested anesthetic solutions, there was complete disappearance of the action potential produced by the C-fibers but not the A-fibers. The VAS is the most widely used tool for estimating both severities of pain and to judge the extent of pain relief [ 36 , 37 ]. The VAS is a continuous scale, which is comprised of a horizontal (HVAS) or vertical (VVAS) line, usually 100 mm long, anchored by two verbal descriptors (i.e., "no pain" and "worst imaginable pain") [ 36 , 38 , 39 ].…”

Section: Discussionmentioning

confidence: 99%

Comparative evaluation of ropivacaine and lidocaine as dental pulp anaesthesia

Senthilkumar

Ramesh

2021

Bioinformation

View full text Add to dashboard Cite

Root canal therapy linked to pulpal diseases or trauma is common in modern dental care. The 2% Lidocaine which is considered as the gold standard has some drawbacks in pulpal anaesthesia. Ropivacaine has beneficial anaesthetic effects on pulpal anaesthesia. Therefore, it is of interest to compare and evaluate the pulpal aesthetic effect using 0.5% Ropivacaine and 2% Lidocaine in symptomatic irreversible pulpitis. A double blinded randomized controlled clinical trial consisting of 110 lower molar and premolar tooth with irreversible pulpitis cases for root canal therapy were selected and randomly divided into 2 groups. Group A: 2% lidocaine with epinephrine and Group B: 0.5% ropivacaine. The pulp sensibility tests with heat test, cold test and electric pulp test were completed. The preoperative pain score was measured with Visual Analogue Scale (VAS) pain scale. Classical inferior alveolar nerve block (IANB) technique was given to all patients by a single operator. Subjects were asked for lip numbness and presence or absence of lip numbness. Postoperative pain scores were recorded during access opening and on placing files in the canal. There is no statistical difference between the groups during pre operative conditions. The mean pain scores within group A and group B is recorded. The difference was found to be statistically significant with p value ≤ 0.05. Significant difference between the mean values after and before the treatment is observed. However, there is no statistical significance between the mean pain scores between the access and pulp. The 0.5% Ropivacaine and 2% Lidocaine with epinephrine does not have any significant difference during access opening. However, 0.5% Ropivacaine groups were effective while placing the file in the canal. Thus, 0.5% Ropivacaine showed better results even though it was not statistically significant for further consideration in this context.

show abstract

A comparison of visual analog scale and shear-wave ultrasound elastography data in fibromyalgia patients and the normal population

Cited by 11 publications

References 18 publications

Whole-Body Photobiomodulation Therapy for Fibromyalgia: A Feasibility Trial

Whole-Body Photobiomodulation Therapy for Fibromyalgia: A Feasibility Trial

Do Psychological Factors Influence the Elastic Properties of Soft Tissue in Subjects with Fibromyalgia? A Cross-Sectional Observational Study

Comparative evaluation of ropivacaine and lidocaine as dental pulp anaesthesia

Contact Info

Product

Resources

About